Hematologic Malignancy
Myelodysplastic Syndrome Post Cytotoxic Therapy
CI-CAN-00003368Explore in graph →
Hematologic6 active trials
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00003368Explore in graph →
Research activity
Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.
| Window | Period | Records (count) | Exact query | Computed | Source |
|---|---|---|---|---|---|
| All time | … → 2026-09-29 | 608 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) | 2026-09-29 | pubmed |
| Last 5 years | 2021-01-01 → 2026-12-31 | 131 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2021/01/01:2026/12/31[dp]) | 2026-09-29 | pubmed |
| Preceding 5-year window | 2020-09-29 → 2025-09-28 | 112 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2020/09/29:2025/09/28[dp]) | 2026-09-29 | pubmed |
| Last 12 months | 2025-09-29 → 2026-09-29 | 26 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2025/09/29:2026/09/29[dp]) | 2026-09-29 | pubmed |
| y2016 | 2016-01-01 → 2016-12-31 | 17 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2016/01/01:2016/12/31[dp]) | 2026-09-29 | pubmed |
| y2017 | 2017-01-01 → 2017-12-31 | 29 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2017/01/01:2017/12/31[dp]) | 2026-09-29 | pubmed |
| y2018 | 2018-01-01 → 2018-12-31 | 21 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2018/01/01:2018/12/31[dp]) | 2026-09-29 | pubmed |
| y2019 | 2019-01-01 → 2019-12-31 | 23 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2019/01/01:2019/12/31[dp]) | 2026-09-29 | pubmed |
| y2020 | 2020-01-01 → 2020-12-31 | 15 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2020/01/01:2020/12/31[dp]) | 2026-09-29 | pubmed |
| y2021 | 2021-01-01 → 2021-12-31 | 27 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2021/01/01:2021/12/31[dp]) | 2026-09-29 | pubmed |
| y2022 | 2022-01-01 → 2022-12-31 | 28 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2022/01/01:2022/12/31[dp]) | 2026-09-29 | pubmed |
| y2023 | 2023-01-01 → 2023-12-31 | 23 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2023/01/01:2023/12/31[dp]) | 2026-09-29 | pubmed |
| y2024 | 2024-01-01 → 2024-12-31 | 22 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2024/01/01:2024/12/31[dp]) | 2026-09-29 | pubmed |
| y2025 | 2025-01-01 → 2025-12-31 | 23 | ("Myelodysplastic Syndrome Post Cytotoxic Therapy"[tiab] OR "t-MDS"[tiab] OR "MDS-pCT"[tiab] OR "Therapy-Related MDS"[tiab] OR "MDS Post Cytotoxic Therapy"[tiab] OR "Therapy Related Myelodysplastic Syndrome"[tiab]) AND (2025/01/01:2025/12/31[dp]) | 2026-09-29 | pubmed |
Data updated 2 days agoSource updated unknownsource: pubmed E-utilities
Literature
Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.
Data not yet available